We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

315 hedge funds and large institutions have $1.99B invested in Amneal Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 115 increasing their positions, 78 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 36

47% more repeat investments, than reductions

Existing positions increased: 115 | Existing positions reduced: 78

14% more funds holding

Funds holding: 277 → 315 (+38)

2% more capital invested

Capital invested by funds: $1.95B → $1.99B (+$39.9M)

0.95% more ownership

Funds ownership: 49.17% → 50.12% (+0.95%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

56% less call options, than puts

Call options by funds: $635K | Put options by funds: $1.44M

Holders
315
Holders Change
+38
Holders Change %
+13.72%
% of All Funds
3.88%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
79
Increased
115
Reduced
78
Closed
36
Calls
$635K
Puts
$1.44M
Net Calls
-$803K
Net Calls Change
-$6.82M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$137M
2
State Street
State Street
Massachusetts
+$36M
3
Invesco
Invesco
Georgia
+$19.3M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$14.4M
5
Principal Financial Group
Principal Financial Group
Iowa
+$11M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$75.2M
2
Millennium Management
Millennium Management
New York
-$40.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$17.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17.1M
5
JG
Jain Global
New York
-$13.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
JFG
326
Jefferies Financial Group
New York
– -$907K -71,992 Closed
A
327
AlphaQuest
New York
– -$834K -66,197 Closed
EP
328
Edgestream Partners
New Jersey
– -$822K -65,230 Closed
Verition Fund Management
329
Verition Fund Management
Connecticut
– -$784K -62,247 Closed
Tudor Investment Corp
330
Tudor Investment Corp
Connecticut
– -$671K -53,288 Closed
ZIM
331
Zacks Investment Management
Illinois
– -$613K -48,625 Closed
Amundi
332
Amundi
France
– -$573K -45,463 Closed
AIM
333
Aigen Investment Management
New York
– -$475K -37,674 Closed
FRM
334
Fox Run Management
Connecticut
– -$425K -33,724 Closed
Aviva
335
Aviva
United Kingdom
– -$316K -25,078 Closed
GCP
336
GSA Capital Partners
United Kingdom
– -$273K -21,657 Closed
DC
337
Diametric Capital
Massachusetts
– -$257K -20,365 Closed
AGM
338
Alpine Global Management
New York
– -$203K -16,083 Closed
Cerity Partners
339
Cerity Partners
New York
– -$182K -14,443 Closed
HW
340
Hamilton Wealth
California
– -$176K -14,000 Closed
FCM
341
Fieldview Capital Management
Michigan
– -$163K -12,971 Closed
PCA
342
Pallas Capital Advisors
Massachusetts
– -$130K -10,355 Closed
KAS
343
Kestra Advisory Services
Texas
– -$127K -10,045 Closed
BG
344
Bellevue Group
Switzerland
– -$99.7K -7,913 Closed
Daiwa Securities Group
345
Daiwa Securities Group
Japan
– -$12K -933 Closed
ACM
346
Accent Capital Management
Ohio
– -$7.56K -600 Closed
MW
347
Merited Wealth
Florida
– -$6.43K -510 Closed
Optiver Holding
348
Optiver Holding
Netherlands
– -$3.38K -268 Closed
FHA
349
Flagship Harbor Advisors
Massachusetts
– -$315 -25 Closed
CA
350
Clearstead Advisors
Ohio
– -$13 -1 Closed
10 11 12 13
14

AMRX Hedge Fund Activity: Q1 2026 in Review

315 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q1 2026, worth a combined $1.99B — up 2.1% from $1.95B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new AMRX positions and 36 closed out — a net gain of 43 holders — while 115 added to existing stakes and 78 trimmed.

The largest buyer was BlackRock, adding an estimated $137M. The largest seller was Citadel Advisors, cutting an estimated $75.2M.

  • 315 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q1 2026, up from 277 in Q4 2025.
  • Funds reported $1.99B of Amneal Pharmaceuticals stock for Q1 2026, up 2.1% quarter-over-quarter.
  • 79 funds opened new Amneal Pharmaceuticals positions in Q1 2026 and 36 closed out, a net change of +43 holders.
  • The largest Amneal Pharmaceuticals buyer in Q1 2026 was BlackRock, an estimated $137M added.
  • The largest Amneal Pharmaceuticals seller in Q1 2026 was Citadel Advisors, an estimated $75.2M sold.

Based on aggregated 13F filings for Q1 2026.